AL
GILD icon

Airain Ltd’s Gilead Sciences GILD Stock Holding History

Airain Ltd’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$6.79M Sell
95,919
-306,277
-76% -$20.4M 0.3% 97
2017
Q1 		$27.3M Buy
402,196
+110,923
+38% +$7.8M 1.34% 4
2016
Q4 		$20.9M Buy
291,273
+156,548
+116% +$11.6M 1.68% 6
2016
Q3 		$10.7M Sell
134,725
-170,677
-56% -$13.9M 0.63% 36
2016
Q2 		$25.5M Buy
305,402
+113,472
+59% +$10.1M 1.47% 4
2016
Q1 		$17.6M Buy
191,930
+36,009
+23% +$3.25M 1.22% 9
2015
Q4 		$15.8M Buy
155,921
+44,970
+41% +$4.68M 1.08% 4
2015
Q3 		$10.9M Sell
110,951
-18,188
-14% -$2.02M 0.65% 19
2015
Q2 		$15.1M Buy
129,139
+27,444
+27% +$3M 0.85% 6
2015
Q1 		$9.98M Buy
101,695
+15,808
+18% +$1.61M 0.61% 35
2014
Q4 		$8.1M Sell
85,887
-11,952
-12% -$1.24M 0.66% 31
2014
Q3 		$10.4M Buy
97,839
+21,153
+28% +$2.07M 0.71% 18
2014
Q2 		$6.36M Buy
+76,686
New +$5.97M 0.52% 41

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Airain Ltd's GILD Position: Q2 2017 in Review

Airain Ltd reduced its Gilead Sciences (GILD) stake by 76% in Q2 2017, selling an estimated $20.4M and leaving 95,919 shares worth $6.79M. The position accounts for 0.3% of the portfolio, ranked #97.

Airain Ltd first reported a position in GILD in Q2 2014 and has held it in 13 quarters since. The position peaked at $27.3M in Q1 2017. 1,519 funds tracked by Wall St. Rank hold GILD as of Q2 2017.

  • Airain Ltd held 95,919 shares of Gilead Sciences worth $6.79M as of Q2 2017.
  • Airain Ltd sold 306,277 Gilead Sciences shares in Q2 2017, an estimated $20.4M.
  • Gilead Sciences made up 0.3% of Airain Ltd's portfolio in Q2 2017, its #97 holding.
  • Airain Ltd first reported a position in Gilead Sciences in Q2 2014 and has held it in 13 quarters since.
  • Airain Ltd's Gilead Sciences position peaked at $27.3M in Q1 2017.
  • 1,519 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2017.

Based on Airain Ltd's 13F filing for Q2 2017, filed 8 Aug 2017.